Details for New Drug Application (NDA): 018770
✉ Email this page to a colleague
The generic ingredient in TORNALATE is bitolterol mesylate. Additional details are available on the bitolterol mesylate profile page.
Summary for 018770
Tradename: | TORNALATE |
Applicant: | Sanofi Aventis Us |
Ingredient: | bitolterol mesylate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.37MG/INH | ||||
Approval Date: | Dec 28, 1984 | TE: | RLD: | No |
Expired US Patents for NDA 018770
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | TORNALATE | bitolterol mesylate | AEROSOL, METERED;INHALATION | 018770-001 | Dec 28, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription